Welcome to Hologic Investor Relations

 Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products. The Company’s core business units focus on diagnostics, breast health, GYN surgical, and skeletal health. With a unified suite of technologies and a robust research and development program, Hologic is dedicated to The Science of Sure.

The Company's Common Stock is listed on the Nasdaq Global Select Market under the trading symbol HOLX.

Recent and Upcoming Events
Wednesday, November 30, 2016
9:00am - 9:25am EST
Wednesday, November 16, 2016
2:15pm - 2:55pm EST
Recent News
Nov 25, 2016

Hologic, Inc. (Nasdaq: HOLX) will highlight its portfolio of innovative, award-winning breast cancer screening and interventional products, including the new Affirm™ prone breast biopsy system,...

Nov 18, 2016

Hologic Inc. (Nasdaq: HOLX) announced today that new guidelines published by the American Society for Radiation Oncology (ASTRO) recommend Accelerated Partial Breast Irradiation (APBI) as a...

Nov 15, 2016

MARLBOROUGH, Mass. (November 15, 2016) – Hologic, Inc. (Nasdaq: HOLX) announced today that it has obtained a CE Mark for the Company’s Herpes Simplex Virus (HSV) assay, enabling the test to be...

Nov 14, 2016

MARLBOROUGH, Mass. November 14, 2016 -- Hologic, Inc. (Nasdaq: HOLX) today announced the launch of its next-generation NovaSure® 6mm global endometrial ablation (GEA) system, the NovaSure®...

More ›